Roxadustat on Renal Anemia with Macroinflammation: A Retrospective Cohort Study
Introduction: Roxadustat, the first-in-class drug for the treatment of renal anemia, has demonstrated efficacy in renal anemia with microinflammation. Additional data are needed regarding the efficacy of roxadustat on renal anemia with systemic macroinflammation. Methods: Three cohorts of renal anem...
Main Authors: | Yan Tu, Zuo-Lin Li, Hong Liu, Ri-Ning Tang, Gui-Hua Wang, Lin-Li Lv, Bin Wang, Bi-Cheng Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2024-03-01
|
Series: | Kidney Diseases |
Subjects: | |
Online Access: | https://beta.karger.com/Article/FullText/538372 |
Similar Items
-
Roxadustat in treating anemia in dialysis patients (ROAD): protocol and rationale of a multicenter prospective observational cohort study
by: Yaling Zhang, et al.
Published: (2021-01-01) -
Roxadustat for Patients with Posttransplant Anemia: A Narrative Review
by: Xiaoxiao Tang, et al.
Published: (2023-11-01) -
Efficacy of Roxadustat on anemia and residual renal function in patients new to peritoneal dialysis
by: Tong Wu, et al.
Published: (2022-12-01) -
Thyroid function analysis after roxadustat or erythropoietin treatment in patients with renal anemia: a cohort study
by: Xiaomeng Zheng, et al.
Published: (2023-12-01) -
Roxadustat: Not just for anemia
by: Xiaoyu Zhu, et al.
Published: (2022-08-01)